Role of adipokine zinc-α2-glycoprotein in coronary heart disease
- 1 December 2019
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 317 (6) , E1055-E1062
Abstract
Zinc-α2-glycoprotein (AZGP1) is a newly identified adipokine that is associated with lipid metabolism and vascular fibrosis. Although adipokines contribute to lipid dysfunction and its related diseases, including stroke and coronary heart disease (CHD), the role of AZGP1 remains unclear. In this study, the role of AZGP1 in atherosclerosis and CHD was investigated. Serum AZGP1 levels from control ( n = 84) and CHD ( n = 91) patients were examined by ELISA and its relationship with various clinical parameters was analyzed. Immunohistochemistry and immunofluorescence were used to detect the expression of AZGP1 and its receptor in coronary atherosclerotic arteries. THP-1 and human embryonic kidney 293 cells were used to verify its anti-inflammatory role in atherosclerosis. Serum AZGP1 levels in CHD patients were lower than controls ( P < 0.01) and independently associated with CHD prevalence ( P = 0.021). AZGP1 levels also inversely correlated with the Gensini score. Immunohistochemistry and immunofluorescence showed that AZGP1 and its receptor β3-adrenoceptor (β3-AR) colocalized in lipid-rich areas of atherosclerotic plaques, particularly around macrophages. In vitro, AZGP1 had no effect on foam cell formation but showed anti-inflammatory effects through its regulation of JNK/AP-1 signaling. In summary, AZGP1 is an anti-inflammatory agent that can be targeted for CHD treatment.Keywords
This publication has 35 references indexed in Scilit:
- Akt1 and Akt2 protein kinases differentially contribute to macrophage polarizationProceedings of the National Academy of Sciences of the United States of America, 2012
- Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year UpdatePhysiological Reviews, 2012
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signalingOncogene, 2010
- Zinc-α2-glycoprotein in cachexia and obesityCurrent Opinion in Supportive & Palliative Care, 2009
- Signalling pathways in alcohol-induced liver inflammationJournal of Hepatology, 2009
- Apolipoprotein C-I Is Crucially Involved in Lipopolysaccharide-Induced Atherosclerosis Development in Apolipoprotein E–Knockout MiceCirculation, 2007
- Endotoxemia, Immune Response to Periodontal Pathogens, and Systemic Inflammation Associate With Incident Cardiovascular Disease EventsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Toll-Like Receptor Signaling PathwaysScience, 2003
- A more meaningful scoring system for determining the severity of coronary heart diseaseThe American Journal of Cardiology, 1983